Biosimilar antibodies developed as therapeutics continue to dominate pipelines and top selling drugs at major pharmaceutical companies. They have proven to be valuable tools in the fight againt devestating diseases from cancer and autoimmune disorders to infectious and neurodegenertive diseases. USBio offers a comprehensive portfolio of antibody drug analogs available to researchers worldwide.
Learn more about our featured Research Grade Biosimilars listings:
Learn MoreUnited States Biological Image Reference
Citation:2023 Biosimilars Forum. All rights reserved.We accept the following payment methods as well as pay-by-invoice.
